ChiCTR2200057110 版本V1.1 版本创建时间2022/11/02 10:37:58 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200057110 

最近更新日期:

Date of Last Refreshed on:

2022-02-28 14:22:47 

注册时间:

Date of Registration:

2022-02-28 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于红外热成像及脉图特征的寒凉因素与女性月经生理状态相关性研究

Public title:

Study on the correlation between cold factors and menstrual physiological state of women based on infrared thermography and pulse characteristics

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于红外热成像及脉图特征的寒凉因素与女性月经生理状态相关性研究

Scientific title:

Study on the correlation between cold factors and menstrual physiological state of women based on infrared thermography and pulse characteristics

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘艺 

研究负责人:

赵汉青 

Applicant:

Liu Yi 

Study leader:

Zhao Hanqing 

申请注册联系人电话:

Applicant telephone:

15100287578

研究负责人电话:

Study leader's
telephone:

17325223981

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2233539703@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhhqtt@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

zyxy.hbu.cn

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

www.x-mol.com/groups/tcm

申请注册联系人通讯地址:

河北省保定市裕华东路342号

研究负责人通讯地址:

河北省保定市裕华东路342号

Applicant address:

342 Yuhua East Road, Baoding City, Hebei Province

Study leader's address:

342 Yuhua East Road, Baoding City, Hebei Province

申请注册联系人邮政编码:

Applicant postcode:

071000

研究负责人邮政编码:

Study leader's postcode:

071000

申请人所在单位:

河北大学

Applicant's institution:

Hebei university

研究负责人所在单位:

河北大学

Affiliation of the Leader:

Hebei university

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

HDFY-LL-2022-053

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

河北大学附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Affiliated Hospital of Hebei University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-02-21 00:00:00

伦理委员会联系人:

于萌

Contact Name of the ethic committee:

Yu Meng

伦理委员会联系地址:

河北省保定市莲池区裕华东路212号

Contact Address of the ethic committee:

212 Yuhua East Road, Lianchi District, Baoding City, Hebei Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

0312-5981513

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

河北大学中医学院

Primary sponsor:

College of TCM Hebei university

研究实施负责(组长)单位地址:

河北省保定市裕华东路342号

Primary sponsor's address:

342 Yuhua East Road, Baoding City, Hebei Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北

市(区县):

保定

Country:

China

Province:

Hebei

City:

Baoding

单位(医院):

河北大学

具体地址:

河北省保定市裕华东路342号

Institution
hospital:

Hebei University

Address:

342 Yuhua Road East, Lianchi District, Baoding, Hebei

经费或物资来源:

自筹

Source(s) of funding:

self-raised

研究疾病:

月经周期  

Target disease:

The menstrual cycle

研究疾病代码:

Target disease code:

研究类型:

病因学/相关因素研究

Study type:

Cause/Relative factors study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究通过观察寒凉因素引发健康女性月经生理状态变化的情况,探求健康女性在接受寒凉刺激前后的红外热像、脉象的客观化变化,并探讨其变化与中医理论的相关联系。  

Objectives of Study:

In this study, the objective changes of infrared thermal images and pulse images of healthy women before and after receiving cold and cold stimulation were investigated by observing the changes of menstrual physiological state caused by cold and cold factors, and the correlation between the changes and traditional Chinese medicine theory was discussed.

药物成份或治疗方案详述:

实验组于经期前10天开始,每日摄入寒凉饮食(冰激凌115g),共摄入5日,经来则止。对照组不进行特殊干预,但应注意保暖,不可摄入寒凉食物,避免寒冷因素的干扰。记录观察前后痛经症状出现率、疼痛视觉模拟评分(VAS)量表、体表各区域热成像及脉象特征、COX痛经症状评价量表(CMSS)、中医证候相关评分标准、相关问卷等共同评价生理状态的改变情况,并于1个月内随访观察VAS和痛经症状评价等指标,观察寒冷对女性月经生理状态的远期影响。 

Description for medicine or protocol of treatment in detail:

The experimental group began to eat a cold diet (115g ice cream) 10 days before menstruation for 5 days until menstruation. The control group did not receive special intervention, but should pay attention to warm, do not eat cold food, to avoid the interference of cold factors. Dysmenorrhea symptoms before and after the record rate, visual analogue scale (VAS) pain scale, thermal imaging to body surface area and pulse condition characteristic, COX dysmenorrhea symptom assessment scale (CMSS), TCM syndrome score standard and related questionnaire to evaluate the changes in physiology, and VAS in 1 months follow-up observation and evaluation indicators such as symptoms, To observe the long-term effect of cold on menstrual physiology. 

纳入标准:

纳入标准:
①18岁-30岁健康女性,全身状况良好,近3个月月经周期(28±7天)、经期(3-7天)、经量等基本正常;
②近3个月内未出现痛经症状;
③患者知晓此研究方案,签署知情同意书,自愿参加并接受分组,依从性佳;
④正式开始本研究入组前2周未服用过止痛、镇静、激素类药物。

Inclusion criteria

Inclusion criteria:
① 18-30 years old healthy female, good general condition, menstrual cycle (28±7 days), menstrual period (3-7 days), menstrual volume in the last 3 months are basically normal;
② No symptoms of dysmenorrhea in the past 3 months;
③ Patients were aware of the study protocol, signed informed consent, voluntarily participated in the study and accepted the grouping, with good compliance;
④ Formal start of this study 2 weeks before enrollment, no analgesic, sedative, hormone drugs were taken.

排除标准:

排除标准:
①排除有子宫附件器质性病变者;
②有其他严重的基础疾病:如严重心血管疾病、代谢性疾病、胃肠疾病(胃炎、肠炎、肠易激综合征等)等及肝炎、结核等处于急性感染期者;
③准备妊娠、妊娠期及哺乳期女性;
④近1个月内参加其他药物临床研究者。

Exclusion criteria:

Exclusion criteria:
① Patients with organic lesions of uterine adnexa were excluded;
② Have other serious underlying diseases, such as serious cardiovascular diseases, metabolic diseases, gastrointestinal diseases (gastritis, enteritis, irritable bowel syndrome, etc.) and hepatitis, tuberculosis and other acute infection stage;
③ Women preparing for pregnancy, pregnancy and lactation;
④ Participate in clinical research of other drugs within the past 1 month.

研究实施时间:

Study execute time:

From 2022-03-01 00:00:00 To 2023-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-03-01 00:00:00 To 2023-03-01 00:00:00

干预措施:

Interventions:

组别:

实验组

样本量:

30

Group:

Experimental group

Sample size:

干预措施:

于经期前10天开始摄入冰激凌

干预措施代码:

Intervention:

Start eating ice cream 10 days before your period

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

保定 

Country:

China

Province:

Hebei

City:

Baoding

单位(医院):

河北大学 

单位级别:

大学 

Institution
hospital:

Hebei university

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

痛经发生率

指标类型:

主要指标

Outcome:

Incidence of dysmenorrhea

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医证候评分

指标类型:

主要指标

Outcome:

TCM syndrome score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟评分

指标类型:

次要指标

Outcome:

VAS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

COX痛经症状评价量表

指标类型:

次要指标

Outcome:

CMSS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

红外热成像

指标类型:

次要指标

Outcome:

Thermal imaging detection

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医脉象

指标类型:

主要指标

Outcome:

Pulse figure characteristics

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医证素

指标类型:

主要指标

Outcome:

TCM syndrome factor

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 30 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

采用简单随机化的方法进行病例的分组。由研究者运用SPSS25.0统计软件包进行随机化分组,将符合纳排标准的患者按先后顺序从数1,2,3……59,60进行编号,数字对应患者入组时的次序,应用SPSS 24.0打开Syntax Editor窗口File→New→Syntax,在SET SEED设定种子取值1-60,生成随机数字,将60个随机数字进行分组、编秩,1-30设为实验组,31-60设为对照组。产生随机种子数和分组结果后,制作随机分配卡片,将卡片置入信封之内,信封上的序号与内置卡片的序号相同。符合纳入排除标准的受试者,按照招募的前后次序,获得相同的信封,拆开信封,按照信封内的卡片要求进入相应的分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients were grouped by simple randomization. SPSS25.0 statistical software package was used for randomization and grouping, and the patients meeting the criteria were selected from number 1,2,3... 59 and 60 were numbered, and the numbers corresponded to the order of patients when they were enrolled. SPSS 24.0

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

NO

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

RESMAN

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

RESMAN

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-02-28 14:22:42